Key result
Supplemental antioxidants have not been generally associated with better cardiovascular outcomes in clinical syndromes leading to platelet-dependent thrombosis.
Design
Review
Authors
Loading...
Antioxidants should not be used to improve outcomes in thrombotic syndromes; leaves open whether targeted redox modulation warrants prospective trials.
The therapeutic value of antioxidants in clinical syndromes leading to platelet-dependent thrombosis remains unclear, as they have not generally improved cardiovascular outcomes and may increase bleeding risk.
Jane E. Freedman (2008) conducted a review in Platelet-dependent thrombosis. Antioxidants was evaluated. Supplemental antioxidants have not been generally associated with better cardiovascular outcomes in clinical syndromes leading to platelet-dependent thrombosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: